Coronavirus

Business & Economics

Wayne Winegarden Quoted in COVID-19 Stimulus Article

Majority of Voters Think Coronavirus Stimulus Package Should Be Top Priority During Biden’s First 100 Days By Rachel Bucchino Amajority of registered voters think President-elect Joe Biden should focus on issues relating to tackling the coronavirus pandemic and a strained economy during his first 100 days in the White House, ...
Commentary

Controlling the Pandemic: Keep It Simple

By Henry Miller, M.S., M.D. and John J. Cohrssen Presumptive President-Elect Joe Biden’s transition organization has published an initial plan to “beat” the rapidly worsening Covid-19 pandemic. Though it is essential and not wholly unreasonable, some parts seem to have been highjacked by a political agenda that contains tangentially related issues. The ...
Blog

No Thanksgiving For You, California

Thanksgiving has not been canceled. Yet. But given what we’ve learned in recent days, would anyone be surprised if officials insisted we mark the holiday this year by cowering in our basements? On Friday, Gov. Gavin Newsom and the governors of Oregon and Washington issued a travel advisory “urging visitors ...
Commentary

Big Pharma’s Hot Streak — and What Could Stop It

The pharmaceutical industry is on a bit of a hot streak. Last Monday, Pfizer announced promising results for its coronavirus vaccine. Later that day, Eli Lilly received emergency-use authorization from the FDA for its antibody treatment, which may prevent COVID-19 from growing serious in patients who contract the coronavirus and ...
Coronavirus

Dr. Henry Miller and John Batchelor Talk Pfizer Vaccine Effectiveness

The John Batchelor Show talks to PRI’s Dr. Henry Miller about the effectiveness of a COVID-19 Pfizer vaccine compared to industry standards. Miller explains the baselines based on current vaccines and talks how a 90 percent effective vaccine could create herd immunity. Batchelor and Miller also talk about the logistics ...
Coronavirus

Dr. Henry Miller Explains Data Behind Pfizer COVID-19 Vaccine

Dr. Henry Miller breaks down the latest announcement from Pfizer about a potential COVID-19 vaccine and look at the numbers around placebo and side-effects. Larson and Miller also talk about the impact of mild symptoms and what those could mean for at-risk Americans and those with co-morbidities and if the ...
Blog

A Work-at-Home Tax?

Ronald Reagan once described the government’s view of the economy like this: “If it moves, tax it. If it keeps moving, regulate it. And if it stops moving, subsidize it.” From his last point, even the Gipper couldn’t imagine that government would tax something that just stayed put. Fast forward ...
Commentary

COVID-phobia – Americans should not fear routine medical care, they worry about not getting it

For America’s doctors, the greatest public health crisis in a generation has been incredibly bad for business. Eighty-one percent of physicians report that their revenues are still below pre-pandemic levels, according to a survey from the American Medical Association. A separate survey conducted earlier this spring found that only one-third of primary care ...
Coronavirus

Dr. Henry Miller Explains Problems with Vaccines and COVID-19

Dr. Henry Miller, M.S., M.D. talks about the impact of a pending vaccine in the United States. Miller also talks about continuing treatments like remdisivir, zinc, and other common treatments to help fight the COVID-19 and how they will play an important role as more vaccine are developed. Larson and ...
Commentary

Fine-Tuning Treatments For COVID-19

President Trump’s COVID-19 recovery has thrust into the spotlight the possibilities of novel, experimental therapies for this potentially deadly disease.  During his stay at Walter Reed National Military Medical Center, he was treated with at least three drugs that have since received substantial attention in the media: the anti-viral remdesivir, ...
Business & Economics

Wayne Winegarden Quoted in COVID-19 Stimulus Article

Majority of Voters Think Coronavirus Stimulus Package Should Be Top Priority During Biden’s First 100 Days By Rachel Bucchino Amajority of registered voters think President-elect Joe Biden should focus on issues relating to tackling the coronavirus pandemic and a strained economy during his first 100 days in the White House, ...
Commentary

Controlling the Pandemic: Keep It Simple

By Henry Miller, M.S., M.D. and John J. Cohrssen Presumptive President-Elect Joe Biden’s transition organization has published an initial plan to “beat” the rapidly worsening Covid-19 pandemic. Though it is essential and not wholly unreasonable, some parts seem to have been highjacked by a political agenda that contains tangentially related issues. The ...
Blog

No Thanksgiving For You, California

Thanksgiving has not been canceled. Yet. But given what we’ve learned in recent days, would anyone be surprised if officials insisted we mark the holiday this year by cowering in our basements? On Friday, Gov. Gavin Newsom and the governors of Oregon and Washington issued a travel advisory “urging visitors ...
Commentary

Big Pharma’s Hot Streak — and What Could Stop It

The pharmaceutical industry is on a bit of a hot streak. Last Monday, Pfizer announced promising results for its coronavirus vaccine. Later that day, Eli Lilly received emergency-use authorization from the FDA for its antibody treatment, which may prevent COVID-19 from growing serious in patients who contract the coronavirus and ...
Coronavirus

Dr. Henry Miller and John Batchelor Talk Pfizer Vaccine Effectiveness

The John Batchelor Show talks to PRI’s Dr. Henry Miller about the effectiveness of a COVID-19 Pfizer vaccine compared to industry standards. Miller explains the baselines based on current vaccines and talks how a 90 percent effective vaccine could create herd immunity. Batchelor and Miller also talk about the logistics ...
Coronavirus

Dr. Henry Miller Explains Data Behind Pfizer COVID-19 Vaccine

Dr. Henry Miller breaks down the latest announcement from Pfizer about a potential COVID-19 vaccine and look at the numbers around placebo and side-effects. Larson and Miller also talk about the impact of mild symptoms and what those could mean for at-risk Americans and those with co-morbidities and if the ...
Blog

A Work-at-Home Tax?

Ronald Reagan once described the government’s view of the economy like this: “If it moves, tax it. If it keeps moving, regulate it. And if it stops moving, subsidize it.” From his last point, even the Gipper couldn’t imagine that government would tax something that just stayed put. Fast forward ...
Commentary

COVID-phobia – Americans should not fear routine medical care, they worry about not getting it

For America’s doctors, the greatest public health crisis in a generation has been incredibly bad for business. Eighty-one percent of physicians report that their revenues are still below pre-pandemic levels, according to a survey from the American Medical Association. A separate survey conducted earlier this spring found that only one-third of primary care ...
Coronavirus

Dr. Henry Miller Explains Problems with Vaccines and COVID-19

Dr. Henry Miller, M.S., M.D. talks about the impact of a pending vaccine in the United States. Miller also talks about continuing treatments like remdisivir, zinc, and other common treatments to help fight the COVID-19 and how they will play an important role as more vaccine are developed. Larson and ...
Commentary

Fine-Tuning Treatments For COVID-19

President Trump’s COVID-19 recovery has thrust into the spotlight the possibilities of novel, experimental therapies for this potentially deadly disease.  During his stay at Walter Reed National Military Medical Center, he was treated with at least three drugs that have since received substantial attention in the media: the anti-viral remdesivir, ...
Scroll to Top